Prosecution Insights
Last updated: April 19, 2026

Merck Sharp & Dohme Corp.

5 pending office actions

Portfolio Summary

5
Total Pending OAs
0
Final Rejections
5
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18137949 METHOD OF TREATING ACUTE MIGRAINE WITH CGRP-ACTIVE COMPOUND SZNAIDMAN, MARCOS L 1628 Non-Final OA Apr 21, 2023
18109281 TREATMENT OF METASTATIC PANCREATIC ADENOCARCINOMA EDGINGTONGIORDANO, FRANCESCA 1643 Non-Final OA Feb 14, 2023
18018660 COMPOSITIONS INCLUDING SOLID FORMS OF POLYPEPTIDES AND RELATED METHODS PRAGANI, RAJAN 1614 Non-Final OA Jan 30, 2023
17633300 DRUG DELIVERY SYSTEM FOR THE DELIVERY OF ANTIVIRAL AGENTS VANHORN, ABIGAIL LOUISE 1636 Non-Final OA Feb 07, 2022
17386958 INSULIN-INCRETIN CONJUGATES KOMATSU, LI N 1658 Non-Final OA Jul 28, 2021

Managing Merck Sharp & Dohme Corp.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month